Engineering TILs to Utilize Kynurenine as an Essential Nutrient for Survival in the Tumor Microenvironment 2021 Partnership with Emerson Collective David Hockenbery, MD, Fred Hutchinson Cancer Research Center Read More
Evolution of Megakaryocyte Abnormalities in the Progression of Primary Myelofibrosis 2021 Mark Foundation for Cancer Research-Leukemia & Lymphoma Society Fellow Johanna Melo-Cardenas, PhD, St. Jude Children’s Research Hospital Read More
Deciphering Immune Cell Heterogeneity and Transcriptomic Changes Associated with CRS Development and Severity in CAR-T Cell Treated Patients 2021 Mark Foundation for Cancer Research-Leukemia & Lymphoma Society Fellow Sylvain Simon, PhD, Fred Hutchinson Cancer Research Center Read More
Evaluating a Novel Collaboration Between NOTCH1 and MLL1 for Improved Targeted Treatments in T-ALL 2021 Mark Foundation for Cancer Research-Leukemia & Lymphoma Society Fellow Therese Vu, PhD, University of Colorado Denver Read More
Cell Morphological Modulation of Oncogenic RAS Signaling 2021 Damon Runyon - Mark Foundation Postdoctoral Fellow Gabriel Muhire Gihana, PhD, University of Texas Southwestern Medical Center Read More
Characterize the Role of Non-Vesicular Cholesterol Transport in CD8+ T Cell Function 2021 Damon Runyon - Mark Foundation Postdoctoral Fellow Yajing Gao, PhD, University of California, Los Angeles Read More
